During the first half of last year, LockBit claimed 433 victims, compared to RansomHub's 123. In the second half, however, RansomHub's victim count shot to 378, compared to LockBit's 93, according to ...
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.